Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

atai Impact

Data updated

Corporate philanthropy initiative launched by atai to support equitable mental-health innovation and psychedelic ecosystem programs.

Foundations & Philanthropy Snapshot

Grant-Making Organizations

Classification

Corporate Philanthropy Program

Geography

Global

Coverage

Global

Last Verified

Apr 10, 2026

Funding Focus Areas

Access & Equity ProgramsAcademic Research Funding

Support Types

Grant FundingProgrammatic Sponsorship

Philanthropy Notes

atai Impact is positioned as a corporate philanthropic platform. Public disclosures include direct donation activity to MAPS and broader equity initiatives.

Verification

Verified

Psychedelic Focus

Explicit Psychedelic Focus

Engagement Status

Active

Primary Funding Link

Funded / Linked Stakeholders

Recorded Funding Activities

MAPS

Jan 1, 2022

Grant Funding - Donation supporting MAPS operations and health equity programming

atai Impact donates to MAPS

Multidisciplinary Association for Psychedelic Studies (MAPS)

Feb 16, 2022

donation - Multi-year donation supporting MAPS' Health Equity Program - $500,000

$500,000 multi-year gift issued through the atai Impact Fund at Vanguard Charitable, earmarked for MAPS' Health Equity Program to build a diverse network of therapy providers and improve access to psychedelic medicine.

atai Impact Donates to MAPS to Support Pioneering Work in Psychedelic Medicine

Mental-health non-profit organisations (Patient Impact grantees)

May 28, 2026

grant - AtaiBeckley Patient Impact Grant Program - three grants of $20,000 each ($60,000 total)

AtaiBeckley (the atai/Beckley Psytech combination that carries atai Impact) launched a grant program awarding three $20,000 grants to mental-health non-profits focused on community support, stigma reduction and ecosystem innovation; application deadline 1 Sept 2026.

Patient Impact - AtaiBeckley

Quick Facts

Website
Visit